Back to search
Non-fluent Aphasia
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Non-fluent Aphasia trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Non-fluent Aphasia trials you may qualify forWhile many have strongly suggested that transcranial direct current stimulation (tDCS) may represent a beneficial intervention for patients with primary progres…
The purpose of this study is to identify and distinguish two different types of Progressive Apraxia of Speech through clinical imaging and testing.
The goal of this clinical trial is to learn whether a personalized, multi-component, virtual speech language treatment program can improve communication and qua…
The goal of this clinical trial is to test the use of voice personalization through artificial intelligence (AI) voice cloning on speech entrainment tasks to im…
The Swedish BioFINDER 2 study is a new study that will launch in 2017 and extends the previous cohorts of BioFINDER 1 study (www.biofinder.se). BioFINDER 1 is u…
Aphasia is an impairment in the ability to express and/or understand language, commonly observed after stroke to the language dominant (left) hemisphere. Despit…
The purpose of this study is to determine safety, tolerability, and pharmacokinetics/dynamics of a ketogenic dietary supplement containing medium chain triglyce…
Aphasia, a communication disorder often resulting from him brain injury such as stroke, impacts an individual's ability to understand or produce language. It ca…
Primary Progressive Aphasia (PPA) is a progressive syndrome in the family of Alzheimer's disease and related disorders involving devastating language impairment…